Integrated network analysis reveals potentially novel molecular mechanisms and therapeutic targets of refractory epilepsies
暂无分享,去创建一个
Xuezhong Zhou | Guangming Liu | Xiaohan Yang | Pin Sun | Pengyao Zhao | Changkai Sun | Xuezhong Zhou | Yiwei Wang | Guangming Liu | Hongwei Chu | P. Zhao | Xiaohan Yang | Tiezheng Zheng | Changkai Sun | Tiezheng Zheng | Yizhun Zhu | Weilin Jin | Weilin Jin | Yizhun Zhu | Hongwei Chu | Jiahui Yin | Yiwei Wang | P. Sun | Jiahui Yin
[1] Tudor Groza,et al. The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..
[2] Michael R. Johnson,et al. Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery , 2016, Genome Biology.
[3] H. Mefford,et al. Advancing epilepsy genetics in the genomic era , 2015, Genome Medicine.
[4] Liyuan Guo,et al. Network analysis reveals a stress-affected common gene module among seven stress-related diseases/systems which provides potential targets for mechanism research , 2015, Scientific Reports.
[5] K. Deisseroth,et al. CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy , 2015, Genes & development.
[6] A. Barabasi,et al. A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. , 2015, Human molecular genetics.
[7] Seung-Hyun Jin,et al. Mesial temporal lobe epilepsy with hippocampal sclerosis is a network disorder with altered cortical hubs , 2015, Epilepsia.
[8] Seok-Gu Kang,et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy , 2015, Nature Medicine.
[9] Philippe Ryvlin,et al. Epilepsy: new advances , 2015, The Lancet.
[10] A. Barabasi,et al. Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.
[11] Yifeng Du,et al. Association of insulin receptor H1085H C>T, insulin receptor substrate 1 G972R and insulin receptor substrate 2 1057G/A polymorphisms with refractory temporal lobe epilepsy in Han Chinese , 2015, Seizure.
[12] M. Wong,et al. mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives , 2015, CNS Drugs.
[13] N. Bazan,et al. Hippocampal Neuro-Networks and Dendritic Spine Perturbations in Epileptogenesis Are Attenuated by Neuroprotectin D1 , 2015, PloS one.
[14] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[15] W. Brackenbury,et al. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis , 2015, Molecular Cancer.
[16] Xuezhong Zhou,et al. Network-based detection of disease modules and potential drug targets in intractable epilepsy , 2014, 2014 8th International Conference on Systems Biology (ISB).
[17] M. Mula,et al. A White Paper on the medical and social needs of people with epilepsy and intellectual disability: The Task Force on Intellectual Disabilities and Epilepsy of the International League Against Epilepsy , 2014, Epilepsia.
[18] X. Tian,et al. Neural mechanisms and potential treatment of epilepsy and its complications. , 2014, American journal of translational research.
[19] Pablo Villoslada,et al. Modules, networks and systems medicine for understanding disease and aiding diagnosis , 2014, Genome Medicine.
[20] M. Ghabaee,et al. Strategies of Starting and Stopping Antiepileptic Drugs in Patients With Seizure or Epilepsy; A Comprehensive Review , 2014 .
[21] Che-Lun Hung,et al. Computational Approaches for Drug Discovery , 2014, Drug development research.
[22] Michael R. Johnson,et al. Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies , 2014, The Lancet Neurology.
[23] Shaobo Zhou,et al. Anti-Epileptic Effect of Ganoderma Lucidum Polysaccharides by Inhibition of Intracellular Calcium Accumulation and Stimulation of Expression of CaMKII α in Epileptic Hippocampal Neurons , 2014, PloS one.
[24] A. Barabasi,et al. Human symptoms–disease network , 2014, Nature Communications.
[25] M. Jacomy,et al. ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software , 2014, PloS one.
[26] Andrey Rzhetsky,et al. DiseaseConnect: a comprehensive web server for mechanism-based disease–disease connections , 2014, Nucleic Acids Res..
[27] J. Téllez-Zenteno,et al. Management of antiepileptic drugs following epilepsy surgery: A meta-analysis , 2014, Epilepsy Research.
[28] Nobili. Seizure-induced pathologic plasticity and cell death in epileptogenic focal cortical dysplasia: converging evidences from human patients and an experimental model , 2014 .
[29] Z. Zuo,et al. Nicotine decreases the activity of glutamate transporter type 3. , 2014, Toxicology letters.
[30] Selim R. Benbadis,et al. Tobacco smoking, epilepsy, and seizures , 2014, Epilepsy & Behavior.
[31] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[32] F Edward Dudek,et al. When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? , 2014, Advances in experimental medicine and biology.
[33] F. Leijten,et al. Prognostic factors for medically intractable epilepsy: A systematic review , 2013, Epilepsy Research.
[34] M. A. Mancano. Dalfampridine-Induced Seizures; Efavirenz-Induced Hypersomnolence Leading to Coma and Death; Cerebral Toxoplasmosis with Rituximab; Torsades de Pointes after Low-Dose Aripiprazole; Atypical Antipsychotic-Induced Sleepwalking , 2013 .
[35] C. Derry,et al. Mild traumatic brain injury and epilepsy: alcohol misuse may underpin the association , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[36] Albert-László Barabási,et al. Network-based Analysis of Genome Wide Association Data Provides Novel Candidate Genes for Lipid and Lipoprotein Traits* , 2013, Molecular & Cellular Proteomics.
[37] Damian Szklarczyk,et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..
[38] R. Dolmetsch,et al. Cacnb4 directly couples electrical activity to gene expression, a process defective in juvenile epilepsy , 2012, The EMBO journal.
[39] Yan Liu,et al. Protein-protein interaction network analysis of children atopic asthma. , 2012, European review for medical and pharmacological sciences.
[40] L. Peelman,et al. Experimental validation of in silico predicted KCNA1, KCNA2, KCNA6 and KCNQ2 genes for association studies of peripheral nerve hyperexcitability syndrome in Jack Russell Terriers , 2012, Neuromuscular Disorders.
[41] J. Britton,et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. , 2012, Archives of neurology.
[42] M. Fichera,et al. Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization. , 2012, Archives of neurology.
[43] I. Scheffer,et al. Genome‐wide linkage meta‐analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies , 2012, Epilepsia.
[44] H. Beck,et al. Antiepileptogenesis, Plasticity of AED Targets, Drug resistance, and Targeting the Immature Brain , 2012 .
[45] Luonan Chen,et al. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach , 2011, BMC Genomics.
[46] Douglas C. Miller,et al. Refractory Epilepsy Associated With Microglial Activation , 2011, The neurologist.
[47] Chuan-Yun Li,et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases , 2011, Nucleic Acids Res..
[48] A. Blight,et al. Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis , 2011, Current medical research and opinion.
[49] D. Bhalla,et al. Etiologies of epilepsy: a comprehensive review , 2011, Expert review of neurotherapeutics.
[50] Zhiyong Lu,et al. PubMed and beyond: a survey of web tools for searching biomedical literature , 2011, Database J. Biol. Databases Curation.
[51] S. Zhi. NMDA receptor in the pathogenesis of epilepsy , 2011 .
[52] M. L. Nunes,et al. Efeitos da epilepsia e da desnutrição no sistema nervoso central em desenvolvimento: aspectos clínicos e evidências experimentais , 2010 .
[53] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[54] S. Picaud,et al. Treatment of epilepsy: the GABA‐transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina , 2008, The European journal of neuroscience.
[55] C. Kuo,et al. Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor. , 2008, Journal of medicinal chemistry.
[56] Jean-Loup Guillaume,et al. Fast unfolding of communities in large networks , 2008, 0803.0476.
[57] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[58] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[59] Yongjin Li,et al. Discovering disease-genes by topological features in human protein-protein interaction network , 2006, Bioinform..
[60] B. Snel,et al. Predicting disease genes using protein–protein interactions , 2006, Journal of Medical Genetics.
[61] H. Möhler. GABAA Receptors in Central Nervous System Disease: Anxiety, Epilepsy, and Insomnia , 2006, Journal of receptor and signal transduction research.
[62] Lincoln Stein,et al. Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Res..
[63] C. Elger,et al. Response: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) , 2005 .
[64] Martin Kuiper,et al. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..
[65] C. Bladen,et al. Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy , 2005, Annals of neurology.
[66] W. Hauser,et al. Comment on Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) , 2005, Epilepsia.
[67] C. Elger,et al. Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) , 2005, Epilepsia.
[68] Jerome V. Murphy,et al. Improving the lives of patients with medically refractory epilepsy by electrical stimulation of the nervous system , 2005, Expert review of medical devices.
[69] Renzo Guerrini,et al. Genetic Malformations of the Cerebral Cortex and Epilepsy , 2005, Epilepsia.
[70] Christian von Mering,et al. STRING: known and predicted protein–protein associations, integrated and transferred across organisms , 2004, Nucleic Acids Res..
[71] M. Kantarci,et al. Valproate-induced Insulin Resistance in Prepubertal Girls with Epilepsy , 2005, Journal of pediatric endocrinology & metabolism : JPEM.
[72] W. Löscher,et al. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions , 2004, Nature Medicine.
[73] Wolfgang Löscher,et al. The neurobiology of antiepileptic drugs , 2004, Nature Reviews Neuroscience.
[74] Joaquín Dopazo,et al. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes , 2004, Bioinform..
[75] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[76] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[77] O. Steinlein. Nicotinic acetylcholine receptors and epilepsy. , 2002, Current drug targets. CNS and neurological disorders.
[78] J. Marín-García,et al. Mitochondrial Dysfunction in Patients With Hypotonia, Epilepsy, Autism, and Developmental Delay: HEADD Syndrome , 2002, Journal of child neurology.
[79] M E J Newman,et al. Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[80] M Thom,et al. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. , 2002, Brain : a journal of neurology.
[81] Mathew W. Wright,et al. The HUGO Gene Nomenclature Committee (HGNC) , 2001, Human Genetics.
[82] A. Barabasi,et al. Lethality and centrality in protein networks , 2001, Nature.
[83] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[84] C. Elger,et al. Increased High‐Density Lipoprotein Cholesterol in Patients with Epilepsy Treated with Carbamazepine: A Gender‐Related Study , 1999, Epilepsia.
[85] H. Duggal,et al. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study. , 1999, Epilepsia.
[86] Duncan J. Watts,et al. Collective dynamics of ‘small-world’ networks , 1998, Nature.
[87] M. Kanehisa,et al. Computation with the KEGG pathway database. , 1998, Bio Systems.
[88] H. Lowe,et al. Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches. , 1994, JAMA.